294 related articles for article (PubMed ID: 29845204)
1. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c.
Zhang Z; Liu J; Wu Y; Zhao X; Hao Y; Wang X; Xue C; Wang Y; Zhang R; Zhang X
Genet Test Mol Biomarkers; 2020 Feb; 24(2):67-72. PubMed ID: 31999493
[No Abstract] [Full Text] [Related]
5. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.
Zhang H; Lu Y; Wang J; Zhang T; Dong C; Li X; Wang X; Ma Q; Yang T; Zhou Y
Mol Med Rep; 2019 Jul; 20(1):292-302. PubMed ID: 31115575
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21.
Zhao J; Zhang C; Gao Z; Wu H; Gu R; Jiang R
J Cell Biochem; 2018 Aug; 119(8):6461-6469. PubMed ID: 29323740
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
10. lncRNA TUSC7 inhibits osteosarcoma progression through the miR‑181a/RASSF6 axis.
Zhao A; Liu W; Cui X; Wang N; Wang Y; Sun L; Xue H; Wu L; Cui S; Yang Y; Bai R
Int J Mol Med; 2021 Feb; 47(2):583-594. PubMed ID: 33416181
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
12. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
Huang Q; Shi SY; Ji HB; Xing SX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
[No Abstract] [Full Text] [Related]
13. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
Zhao J; Ma ST
Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
17. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
[TBL] [Abstract][Full Text] [Related]
18. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells.
Kong G; Qi XJ; Wang JF
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
[TBL] [Abstract][Full Text] [Related]
20. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]